Showing results (1191-1200 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|January 11, 2001
Economic impact of tibolone compared with continuous-combined hormone replacement therapy. In the management of postmenopausal women with climacteric symptoms in the UKJ M Plumb, J F GuestPharmacoeconomics|September 19, 2002
Cost-effectiveness comparison of tizanidine and baclofen in the management of spasticityDavid N Rushton, Adam C Lloyd, Pippa M AndersonPharmacoeconomics|August 31, 2002
Valuation of symptomatic hepatitis a in adults: estimates based on time trade-off and willingness-to-pay measurementR Jake Jacobs, Ronald J Moleski, Allen S MeyerhoffPharmacoeconomics|August 31, 2002
Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteriaXavier Badia, Fermin Mearin, Agustin Balboa, et al.Pharmacoeconomics|October 13, 2001
The cost effectiveness of stratified care in the management of migraineP Williams, A J Dowson, A M Rapoport, et al.Pharmacoeconomics|October 13, 2001
Incremental cost analysis of ambulatory clinic and home-based intravenous therapy for patients with multiple myelomaP C Coyte, M J Dobrow, L BroadfieldPharmacoeconomics|December 12, 2001
Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in australia (1991 to 1996)B George, A Harris, A MitchellPharmacoeconomics|September 20, 2002
The development and use of quality-of-life measures to evaluate health outcomes in JapanShunichi Fukuhara, Naoki Ikegami, George W Torrance, et al.Pharmacoeconomics|October 31, 2002
Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitusChristopher J Dunn, Greg L PloskerPharmacoeconomics|July 3, 2002
Limitations of the methods used for calculating quality-adjusted life-year valuesGérard Duru, Jean Paul Auray, Ariel Béresniak, et al.Pageof 336